Home › Squamous Cell Carcinoma
Squamous Cell Carcinoma clinical trials recruiting in the U.S.
50 studies for Squamous Cell Carcinoma are recruiting participants at sites across the United States.
Cities with the most studies
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- New York City, NY7 studies
- Nashville, TN7 studies
- Houston, TX7 studies
- Atlanta, GA5 studies
- Queens, NY4 studies
- Washington, DC4 studies
- Arlington, VA4 studies
- Orlando, FL4 studies
- Durham, NC4 studies
- Tampa, FL4 studies
- Staten Island, NY3 studies
- Baltimore, MD3 studies
- Rochester, NY3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
- Dallas, TX3 studies
- San Diego, CA3 studies
- Charleston, SC3 studies
- Indianapolis, IN3 studies
- Chicago, IL3 studies
By state
- California12 studies
- Florida11 studies
- Georgia5 studies
- Illinois4 studies
- Indiana3 studies
- Maryland4 studies
- Massachusetts8 studies
- Missouri3 studies
- New York15 studies
- North Carolina5 studies
- Ohio5 studies
- Pennsylvania13 studies
- South Carolina4 studies
- Tennessee7 studies
- Texas11 studies
- Virginia6 studies
Recently updated studies
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07285044JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT04892173Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379Intratumoral N17350 in Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07339176Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06736379Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05027633Effects of Infusion Timing on Treatment Response in Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07630168Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07513389A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06561685A Study of IDP-001 in Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07602842Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 2, 2026 · NCT04915183Toripalimab With Chemotherapy for Sinus Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT06940180T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Aug 31, 2026 · NCT02133196Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Recruiting
All ages · All sexes · Updated Aug 19, 2026 · NCT07682831Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Recruiting
All ages · All sexes · Updated Aug 19, 2026 · NCT07773688A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07115043Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Recruiting
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07241585A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT02507141Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06819228Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT04198766Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT05388773Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06615635PDT For Induction Therapy For Head And Neck Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07214987From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.